Effect of scFOS on Increase in Stool Frequency in Constipated People
NCT ID: NCT03707002
Last Updated: 2018-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
186 participants
INTERVENTIONAL
2015-10-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of scFOS on Stool Frequency in People With Functionnal Constipation
NCT01847950
Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults
NCT02140749
Dietary Supplementation Effects on Bowel Movement Frequency and Intestinal Biological Markers in Seniors Presenting Slowed Intestinal Transit
NCT04304170
Effect of Probiotics on Functional Constipation in Adults
NCT04437147
Evaluating the Effectiveness of LACTOFOS in Constipated Patients
NCT01286376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
scFOS
scFOS consumed at 5g/day for 6 weeks
scFOS
daily intake for 6 weeks
Placebo
maltodextrin consumed at 5g/day for 6 weeks
Maltodextrin
daily intake for 6 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
scFOS
daily intake for 6 weeks
Maltodextrin
daily intake for 6 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18 and 32kg/m², limits included
* Subjects who do not usually eat high-fibre foods
* Subjects who do not usually consume foods siad "reduced in sugars" or "light"
* Subjects who do not consume regularly pre- and probiotics in the form of dietary supplements
Exclusion Criteria
* history of chronic GI disorders: crohn disease, ulcerative colitis,....
* treatments likely to influence GI sensitivity or motility (laxative, neuroleptics,...)
* Antibiotic therapy in progress or in the past 8 weeks
* medical history with impact on the study objectives as defined by investigator
* known food allergy to one of the compounds of the study product
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biofortis Mérieux NutriSciences
OTHER
CreaBio Rhone-Alpes
UNKNOWN
Syral
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Gendre, MD
Role: PRINCIPAL_INVESTIGATOR
BioFortis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biofortis SAS
Saint-Herblain, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEC14513
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.